Jaykay Enterprises Subsidiary Neumesh Labs Receives MCA Investigation Notice

1 min read     Updated on 02 May 2026, 08:42 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Jaykay Enterprises Limited informed stock exchanges about an investigation notice received by its subsidiary Neumesh Labs Private Limited from the Ministry of Corporate Affairs on April 30, 2026. The notice seeks information and documents for examination, with the company committing full cooperation and stating no specific violations have been alleged with no immediate material impact identified.

powered bylight_fuzz_icon
39173009

*this image is generated using AI for illustrative purposes only.

Jaykay Enterprises Limited has informed stock exchanges about an investigation notice received by its subsidiary from regulatory authorities. The disclosure was made on May 01, 2026, in compliance with SEBI listing regulations and follows an earlier intimation dated June 19, 2025.

Investigation Notice Details

Neumesh Labs Private Limited, a subsidiary of Jaykay Enterprises, received a notice of investigation from the Office of the Regional Director (Northern Region), Ministry of Corporate Affairs (MCA) on April 30, 2026. The notice seeks information and documents for examination purposes.

Parameter: Details
Authority: Office of the Regional Director (Northern Region), MCA
Notice Received: April 30, 2026
Subsidiary Affected: Neumesh Labs Private Limited
Nature of Action: Investigation notice seeking documents for examination
Filing Date: May 01, 2026

Company Response and Compliance

The company stated that Neumesh Labs will extend necessary cooperation to the authorities and is currently in the process of submitting the required information and documents sought by MCA. The disclosure was signed by Company Secretary and Compliance Officer Shikha Rastogi and communicated to both BSE Limited and National Stock Exchange of India Ltd.

Regulatory Filing Requirements

The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 in its filing.

Compliance Parameter: Details
Regulation: SEBI Listing Regulations 30
BSE Scrip Code: 500306
NSE Symbol: JAYKAY
Company Secretary: Shikha Rastogi
Website Disclosure: www.jaykayenterprises.com

Impact Assessment

According to the disclosure, no specific violation or contravention has been stated in the communication received from MCA. The company has assessed that no immediate material impact has been identified on its financial, operational, or other activities as of the disclosure date.

Assessment Category: Status
Specific Violations Alleged: None stated
Material Financial Impact: No immediate impact identified
Operational Impact: No immediate impact identified
Company Cooperation: Full cooperation committed

Historical Stock Returns for Jaykay Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+0.59%+11.04%+42.82%-14.03%-14.03%-14.03%

What potential regulatory changes or compliance gaps might have triggered MCA's investigation into Neumesh Labs' operations?

How could this investigation affect Jaykay Enterprises' ability to secure future business partnerships or financing arrangements?

Will the MCA investigation prompt similar scrutiny of other subsidiaries within Jaykay Enterprises' portfolio?

Jaykay Enterprises subsidiary JK Digital secures ISO certifications for medical implants manufacturing

1 min read     Updated on 26 Apr 2026, 08:49 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

JK Digital & Advance Systems Private Limited, a wholly owned subsidiary of Jaykay Enterprises Limited, has been awarded ISO 13485:2016 and ISO 9001:2015 certifications by BSCIC Certifications Private Limited. The certifications cover the manufacture and sale of additive manufactured sterile revision surgery hip implants, augments, spinal implants, and patient-specific implants. Both certificates are valid from April 25, 2026, to April 24, 2029, with surveillance audits scheduled annually.

powered bylight_fuzz_icon
38762377

*this image is generated using AI for illustrative purposes only.

JK Digital & Advance Systems Private Limited, a wholly owned subsidiary of jaykay enterprises , has been awarded ISO 13485:2016 and ISO 9001:2015 certifications by BSCIC Certifications Private Limited. The certifications were received under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with the disclosure dated April 26, 2026.

Certification Details

The ISO 13485:2016 certification is specifically for Medical Device - Quality Management System, while ISO 9001:2015 covers Quality Management System. Both certifications apply to the manufacture and sale of additive manufactured sterile revision surgery hip implants, augments, spinal implants, and patient-specific implants. The technical area for ISO 13485:2016 includes Non-Active Implants, Non-Active Orthopaedic Implants, A.1.1.12, and Ethylene Oxide Gas Sterilization (EOG), A.1.5.1.

Certificate Validity and Schedule

Both certifications have been issued with the following timeline:

Originally Registered: 25-Apr-2026 1st Surveillance Due on: 24-Apr-2027
Issue Date: 25-Apr-2026 2nd Surveillance Due on: 24-Apr-2028
Expiry Date: 24-Apr-2029

The certificate numbers are BN25082/23560 for ISO 13485:2016 and BN25082/23561 for ISO 9001:2015. Both certificates are subject to annual surveillance audits, and failure to conduct these audits may result in suspension or withdrawal of the certifications.

Business Impact

The receipt of these ISO certifications marks an important milestone for JK Digital's Medical Implants business. The certifications pave the way for end-to-end manufacturing solutions leveraging JK Digital's Additive Manufacturing capabilities. The subsidiary is located at First and Second Floor, Plot 477B, 4th Phase, Peenya Industrial Area, 12th Cross, Bengaluru, Karnataka.

Historical Stock Returns for Jaykay Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+0.59%+11.04%+42.82%-14.03%-14.03%-14.03%

What revenue growth targets has Jaykay Enterprises set for its medical device subsidiary following these ISO certifications?

Which international markets is JK Digital planning to enter with its certified additive manufacturing capabilities?

How will these certifications impact Jaykay Enterprises' competitive positioning against established medical device manufacturers in India?

More News on Jaykay Enterprises

1 Year Returns:-14.03%